Document Report Card
Basic Information
ID: ALA4118129
Journal: Bioorg Med Chem Lett
Title: Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.
Authors: Agarwal S, Sasane S, Kumar J, Deshmukh P, Bhayani H, Giri P, Giri S, Soman S, Kulkarni N, Jain M.
Abstract: TGR5 is a member of G protein-coupled receptor (GPCR) superfamily, a promising molecular target for metabolic diseases. Activation of TGR5 promotes secretion of glucagon-like peptide-1 (GLP-1), which activates insulin secretion. A series of 2-thio-imidazole derivatives have been identified as novel, potent and orally efficacious TGR5 agonists. Compound 4d, a novel TGR5 agonist, in combination with Sitagliptin, a DPP-4 inhibitor, has demonstrated an adequate GLP-1 secretion and glucose lowering effect in animal models, suggesting a potential clinical option in treatment of type-2 diabetes.
CiteXplore: 29655980